<DOC>
	<DOCNO>NCT02057029</DOCNO>
	<brief_summary>Investigators examine impact Breast Cancer Index ( BCI ) result patient ' anxiety / fear recurrence satisfaction decision regard endocrine therapy .</brief_summary>
	<brief_title>Assessment Decision-making Impact Breast Cancer Index Recommending Extended Adjuvant Endocrine Therapy Patients With Early Stage ER-positive Breast Cancer</brief_title>
	<detailed_description>The investigator ' objective ass patient decision-making , anxiety patient satisfaction recommendation make oncologist BCI test result know . In addition , chart review perform annually five year assess disease status medication . Specifically , extend endocrine therapy recommend chart review record participant take medication , , treatment discontinue .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Each patient must meet follow criterion order consider enrollment : Histologically confirm ER positive , stage IIII breast cancer treat curative intent complete least four year adjuvant endocrine therapy . Life expectancy â‰¥ 5 year . Must able provide inform consent . Willing consider continuation endocrine therapy beyond 5 year . A patient must enrol contraindication exists extend adjuvant endocrine therapy identify treat oncologist .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Estrogen Receptor ( ER ) Positive</keyword>
	<keyword>Early Stage Breast Cancer</keyword>
	<keyword>Breast Cancer Index</keyword>
</DOC>